116 related articles for article (PubMed ID: 8534316)
1. Relative resistance of rabbits to MPTP neurotoxicity.
Lermontova N; Drany O; Dobrota D; Mezesova V; Lombardi V; Bachurin S
Mol Chem Neuropathol; 1995; 25(2-3):135-41. PubMed ID: 8534316
[TBL] [Abstract][Full Text] [Related]
2. Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains.
Riachi NJ; Behmand RA; Harik SI
Brain Res; 1991 Jul; 555(1):19-24. PubMed ID: 1933326
[TBL] [Abstract][Full Text] [Related]
3. Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Oishi T; Hasegawa E; Murai Y
J Neural Transm Park Dis Dement Sect; 1993; 6(1):45-52. PubMed ID: 8105797
[TBL] [Abstract][Full Text] [Related]
4. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Miele M; De Natale G; Miele E
Neurosci Lett; 1993 Oct; 161(2):121-3. PubMed ID: 7903798
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the neurotoxicity of MPTP in rats of different ages.
Lee EH; Liu SP; Lu KT; Lin WR
Chin J Physiol; 1992; 35(4):317-36. PubMed ID: 1364057
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
Dluzen DE
Brain Res; 1996 Apr; 715(1-2):113-8. PubMed ID: 8739629
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice.
Fuller RW; Hemrick-Luecke SK
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):687-90. PubMed ID: 3878976
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.
Carr LA; Rowell PP
Neuropharmacology; 1990 Mar; 29(3):311-4. PubMed ID: 2325834
[TBL] [Abstract][Full Text] [Related]
9. Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity.
Del Zompo M; Piccardi MP; Ruiu S; Quartu M; Gessa GL; Vaccari A
Br J Pharmacol; 1993 Jun; 109(2):411-4. PubMed ID: 8102929
[TBL] [Abstract][Full Text] [Related]
10. Plasticity of the nigrostriatal system in MPTP-treated mice. A biochemical and morphological correlation.
Cruz-Sanchez FF; Cardozo A; Ambrosio S; Tolosa E; Mahy N
Mol Chem Neuropathol; 1993; 19(1-2):163-76. PubMed ID: 8103334
[TBL] [Abstract][Full Text] [Related]
11. Rapid eye movement sleep deprivation enhances vulnerability of striatal dopaminergic neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice.
Mitsumoto Y; Nagai Y; Takata R; Mori A
Psychogeriatrics; 2020 Jan; 20(1):129-130. PubMed ID: 31012197
[No Abstract] [Full Text] [Related]
12. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
Moy LY; Albers DS; Sonsalla PK
Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
[TBL] [Abstract][Full Text] [Related]
13. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.
Rose S; Nomoto M; Jackson EA; Gibb WR; Jenner P; Marsden CD
Eur J Pharmacol; 1990 May; 181(1-2):97-103. PubMed ID: 2117541
[TBL] [Abstract][Full Text] [Related]
14. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
Heikkila RE
Eur J Pharmacol; 1985 Oct; 117(1):131-3. PubMed ID: 3878793
[TBL] [Abstract][Full Text] [Related]
15. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
[TBL] [Abstract][Full Text] [Related]
16. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444
[TBL] [Abstract][Full Text] [Related]
17. Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment.
Hadjiconstantinou M; Neff NH
Eur J Pharmacol; 1990 May; 181(1-2):137-9. PubMed ID: 1974854
[TBL] [Abstract][Full Text] [Related]
18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxicity risk assessment of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) as a synthetic impurity of drugs.
Kramer PJ; Caldwell J; Hofmann A; Tempel P; Weisse G
Hum Exp Toxicol; 1998 May; 17(5):283-93. PubMed ID: 9663939
[TBL] [Abstract][Full Text] [Related]
20. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
